Tvardi Therapeutics, Inc. (TVRD) Financials

TVRD Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 17.5 million 9.1 million
March 31, 2026 25.8 million 11.3 million
Dec. 31, 2025 32.1 million 11.1 million
Sept. 30, 2025 39.0 million 11.2 million

TVRD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -9.2 million ?
March 31, 2026 -5.9 million 370000
Dec. 31, 2025 -5.7 million 353000
Sept. 30, 2025 -4.3 million 339000

TVRD Net Income

No data available :(

TVRD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 15.8 million - 145000
March 31, 2026 25.0 million - 174000
Dec. 31, 2025 30.8 million - 201000
Sept. 30, 2025 36.5 million - 228000

TVRD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 9.4 million
March 31, 2026 9.4 million
Dec. 31, 2025 9.4 million
Sept. 30, 2025 9.4 million

TVRD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 4.0 million 2.6 million -
March 31, 2026 - 4.9 million 2.1 million 46000
Dec. 31, 2025 - 5.5 million 2.1 million 46000
Sept. 30, 2025 - 3.6 million 2.3 million 45000

TVRD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -

TVRD

Price: $1.86

52 week price:
1.50
43.65

Earnings Per Share: -2.87 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 25.3 million

Links: